
Get Thin MD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8/10
Best for: flat-priced compounded semaglutide or tirzepatide, with brand-name options too
Get Thin MD scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
Price checked on Get Thin MD's site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
Get Thin MD is a nationwide online telehealth service offering compounded semaglutide and tirzepatide injections, with brand-name Ozempic and Zepbound also available, plus a broader wellness menu (sermorelin, NAD+, HRT, hair loss). It advertises the same price at every dose with no hidden fees. Compounded semaglutide is $199/month month-to-month or $169/month on a 3-month plan paid upfront, and compounded tirzepatide is $299/month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Get Thin MD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Get Thin MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Ozempic, Zepbound
- Starting price
- $199/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Get Thin MD
Each dimension is scored algorithmically from Get Thin MD'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $199/mo, Get Thin MD runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Get Thin MD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.8/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.7/10Get Thin MD treats patients in all 50 states.
Support10%
7.6/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Get Thin MD review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Noted its stated service area; it publishes no state-by-state list
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$299/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Get Thin MD
We walked Get Thin MD's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1The GLP-1 page shows plan prices and a 'Check My Eligibility' button.
- 2The quiz opens by asking your height, weight, goal weight, sex and date of birth.
- 3Per the site, you check out, then a licensed provider reviews your answers and, if approved, writes a prescription.
- 4Medication ships from a partner pharmacy, with a monthly refill form after that.
- Plan prices ($169 to $299/mo) are shown before intake, along with a 'Spring Sale' countdown banner still running in November.
- The $119/mo sale price is footnoted as a 3-month-plan first-month discount on one page and a 12-month plan on another.
- The terms say the initial payment is due the day your provider reviews your visit and is non-refundable.
- Canceling is simple: skip the refill form, call or email, effective in 36 hours.
- 'Bloodwork is not required, but it's always recommended'; no live video visit is stated as mandatory.
Get Thin MD customer support
- Phone
- +1-888-220-0740
- Hours
- Mon-Sun 8am-10pm EST
GLP-1 medications Get Thin MD offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Get Thin MD offers
Beyond GLP-1s, Get Thin MD also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Same price at every dose. Longer plan: 3-month $169/mo, paid upfront (about $507). A rolling 'Spring Sale' advertises 'as low as $119/mo' as a first-month discount on the 3-month plan (the homepage footnote says 12-month plan).
Same price at every dose. The FAQ separately quotes $179 for tirzepatide, which does not match the $299 plan card.
Ready to get started?
Plans and promotions change often, so check Get Thin MD's current pricing and active discounts before you decide.
What we like
- Same price at every dose, so your bill doesn't climb as you titrate up
- Monthly fee covers medication, provider review, care coaching and free expedited shipping
- Month-to-month plan you can cancel anytime by email, phone or skipping the refill form
- Both compounded and brand-name options on one platform (sema, tirz, plus Ozempic and Zepbound)
- Nationwide availability with an online evaluation and 24/7 care team access
- Trustpilot profile with thousands of reviews averaging 4.6 out of 5
- Publishes the FDA compounded-medication disclaimer
Watch-outs
- Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s
- Fees are non-refundable once paid, and the first payment is due when the provider reviews your visit
- A 'Spring Sale' countdown was still running in November, and its $119 offer is described inconsistently across pages
- The best $169/mo semaglutide rate requires paying for 3 months upfront
- Pharmacy partners not named, so you can't check the compounding source
- Claims nationwide coverage but publishes no state list; confirm at intake
- Headline results (9.6 lbs in 30 days) come from self-reported patient data, not a trial
The verdict: a flat-rate option with a month-to-month plan and a cheaper 3-month prepay
Get Thin MD (legally Get Thin MD LLC) is a nationwide, fully async telehealth service whose entire pitch is summed up by its tagline: "same price, every dose, no hidden fees." That price-lock promise is the main reason to look here. Unlike the many platforms that raise your bill as you titrate up to higher GLP-1 doses, Get Thin MD says your monthly cost stays put no matter what dose you land on. If you want predictable compounded semaglutide pricing and the freedom to cancel any month, this is a reasonable pick. Paying for three months upfront lowers the rate. If you want a brand-name GLP-1 covered by insurance or a high-touch clinical relationship, look elsewhere.
How the pricing works, and where the cheap number comes from
Get Thin MD uses a flat, dose-independent model. Compounded semaglutide is $199 per month on the month-to-month plan. The 3-month plan drops that to $169 a month, but you pay all three months upfront. A rolling "Spring Sale" also advertises rates as low as $119 a month. The site describes that offer inconsistently, and its countdown was still running in November 2026. Treat it as a teaser, not a deadline. For context, the category median sits around $179, so the monthly plan lands a little above the middle of the pack. The flat-dose structure is the patient-friendly part. Many people see their bill balloon elsewhere at maintenance doses, and that doesn't happen here.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
- Compounded semaglutide: $199/mo month to month, or $169/mo on the 3-month plan paid upfront
- Spring Sale banner: as low as $119 a month, an offer the site describes inconsistently
- Compounded tirzepatide is also offered at a higher flat monthly rate
- Cancel anytime by email, phone or by skipping the refill form; fees already paid are non-refundable
- Price-lock promise: "your price will never increase, no matter what dose you're on"
What your monthly fee covers
The flat price is all-in. Get Thin MD says each monthly payment covers the prescription medication itself, a licensed provider's review of your intake, a personalized treatment plan, ongoing care coaching, and free expedited shipping. There are no office visits and no insurance to wrangle. The whole evaluation happens asynchronously through an online questionnaire. That bundling is part of why the headline number is easy to compare against rivals that add separate consult or shipping fees.
The medications: compounded first, brand-name available
The core catalog is injectable compounded semaglutide and injectable compounded tirzepatide. For patients who want or need the FDA-approved versions, Get Thin MD also says it can prescribe brand-name Ozempic and Zepbound "where appropriate." That dual menu is convenient. You can start on a lower-cost compounded formula and have a path to brand-name drugs on the same platform. The compounded products are still the headliners and the affordable ones. The brand-name route depends on medical appropriateness and won't carry these flat prices.
Dose-locked pricing, a wide menu, and the upsell that comes with it
Two things make Get Thin MD distinct. First is that flat, dose-locked pricing, which removes the most common nasty surprise in GLP-1 telehealth. Second is the breadth of its menu: this isn't a weight-loss-only shop. The same platform sells sermorelin injections, NAD+, HRT/estradiol, and hair-loss products, so someone running multiple wellness protocols can consolidate them in one place. The flip side of that breadth is a wide sales funnel. Expect to be offered add-on protocols that have nothing to do with weight loss, and stay focused on what you came for.
Trust, safety and what Get Thin MD leaves out
Get Thin MD's own site backs up most of what it claims, but it leaves some gaps. To its credit, the company publishes the required FDA disclaimer that "the FDA does not review or approve any compounded medications for safety or effectiveness," and there are no FDA warning letters on file for the business. But the platform does not name its compounding pharmacy partners, so there's no way for an outsider to confirm the source of the drug or whether batches are independently tested. For a compounded medicine, that is a serious transparency gap. It also markets itself as "available nationwide" without publishing an actual state-by-state list, so confirm your state is served at intake.
- Publishes the FDA compounded-medication disclaimer and shows no FDA warning letters
- Compounded drugs are not FDA-approved and lack the review brand-name GLP-1s receive
- Pharmacy partners are not disclosed, so the compounding source and batch testing can't be checked; Renlo Health, also flat-priced, names both its pharmacy and its medical group
- "Nationwide" is claimed but no state list is published; confirm coverage before paying
- The "9.6 lbs in 30 days" figure comes from self-reported patient data, not a clinical trial
Who should choose it, and who should skip it
Choose Get Thin MD if you want compounded semaglutide with a price that won't climb as your dose does, and you like having a month-to-month plan with a cheaper prepay option. It also suits people who value a no-insurance, no-visit process plus an optional broader wellness menu. Skip it if you specifically want an insurance-billed brand-name prescription, or if you need a named pharmacy you can look up and detailed batch documentation before you'll inject a compounded product. Skip it too if you prefer a provider that lists exactly which states it operates in up front. Spanish speakers have an option in REMEVi, which runs every step in English or Spanish and also keeps one price at every dose.
Bottom line
Get Thin MD is a solid mid-priced pick for compounded GLP-1 treatment, and its dose-locked flat pricing is a meaningfully patient-friendly feature in a category full of creeping bills. The trade-off is transparency: undisclosed pharmacy partners and a vague nationwide claim mean you're trusting the brand more than the paper trail. Go in knowing the month-to-month cost is $199, not the $119 teaser. Confirm your state and the medication source at intake, and read our scoring methodology to see how we weigh price against disclosure.
The Bottom Line
Get Thin MD scores highest on state availability and ease of access.
Ready to start with Get Thin MD?
From $199/mo. See current pricing and start your online intake.
Get Thin MD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Get Thin MD vs…
Get Thin MD scores8.0/10
Side-by-side pricing, medications and scores. Pick a matchup.
Get Thin MD vs Amazon One Medical
Amazon One Medical scores 8.5/10

Get Thin MD vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Get Thin MD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Get Thin MD's current pricing
Plans from $199/mo. Start the online intake to check eligibility and today's price.